Home >> Marketplace Directory >> Hematogenix offers THxID-BRAF, 5/14

Hematogenix offers THxID-BRAF, 5/14

image_pdfCreate PDF

May 2014—BioMérieux’s THxID-BRAF companion diagnostic test is now available through Hematogenix Laboratory Services. The kit is an in vitro diagnostic device to qualitatively detect the BRAF V600E and V600K mutations in DNA samples extracted from formalin-fixed, paraffin-embedded human melanoma tissue. Hematogenix will provide results within three to four business days upon receipt of the specimen. Hematogenix had participated in the test’s clinical development.

Hematogenix, 708-468-8807

CAP TODAY
X